BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32787262)

  • 1. Phosphorylation-Inducing Chimeric Small Molecules.
    Siriwardena SU; Munkanatta Godage DNP; Shoba VM; Lai S; Shi M; Wu P; Chaudhary SK; Schreiber SL; Choudhary A
    J Am Chem Soc; 2020 Aug; 142(33):14052-14057. PubMed ID: 32787262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Reprogramming of Kinases Expands Cellular Activities of Proteins.
    Shoba VM; Munkanatta Godage DNP; Chaudhary SK; Deb A; Siriwardena SU; Choudhary A
    Angew Chem Int Ed Engl; 2022 Jul; 61(29):e202202770. PubMed ID: 35641438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Applications of Chimera Platforms for Tyrosine Phosphorylation.
    Pergu R; Shoba VM; Chaudhary SK; Munkanatta Godage DNP; Deb A; Singha S; Dhawa U; Singh P; Anokhina V; Singh S; Siriwardena SU; Choudhary A
    ACS Cent Sci; 2023 Aug; 9(8):1558-1566. PubMed ID: 37637727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Substrate-Mediated Selection with c-Src Tyrosine Kinase to a DNA-Encoded Chemical Library.
    Kim D; Sun Y; Xie D; Denton KE; Chen H; Lin H; Wendt MK; Post CB; Krusemark CJ
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31366048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifunctional modalities for repurposing protein function.
    Modell AE; Lai S; Nguyen TM; Choudhary A
    Cell Chem Biol; 2021 Jul; 28(7):1081-1089. PubMed ID: 34270935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanopore Enzymology to Study Protein Kinases and Their Inhibition by Small Molecules.
    Harrington L; Alexander LT; Knapp S; Bayley H
    Methods Mol Biol; 2021; 2186():95-114. PubMed ID: 32918732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA-Encoded Chemical Library.
    Cuozzo JW; Centrella PA; Gikunju D; Habeshian S; Hupp CD; Keefe AD; Sigel EA; Soutter HH; Thomson HA; Zhang Y; Clark MA
    Chembiochem; 2017 May; 18(9):864-871. PubMed ID: 28056160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein kinases in canine basilar artery in vasospasm.
    Fujikawa H; Tani E; Yamaura I; Ozaki I; Miyaji K; Sato M; Takahashi K; Imajoh-Ohmi S
    J Cereb Blood Flow Metab; 1999 Jan; 19(1):44-52. PubMed ID: 9886354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study.
    Yamazoe S; Tom J; Fu Y; Wu W; Zeng L; Sun C; Liu Q; Lin J; Lin K; Fairbrother WJ; Staben ST
    J Med Chem; 2020 Mar; 63(6):2807-2813. PubMed ID: 31874036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.
    Liang C; Tian D; Ren X; Ding S; Jia M; Xin M; Thareja S
    Eur J Med Chem; 2018 May; 151():315-326. PubMed ID: 29631132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells.
    Mu X; Bai L; Xu Y; Wang J; Lu H
    Biochem Biophys Res Commun; 2020 Jan; 521(4):833-839. PubMed ID: 31708096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hide and seek: Identification and confirmation of small molecule protein targets.
    Ursu A; Waldmann H
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3079-86. PubMed ID: 26115575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta.
    Blois JT; Mataraza JM; Mecklenbraüker I; Tarakhovsky A; Chiles TC
    J Biol Chem; 2004 Jul; 279(29):30123-32. PubMed ID: 15138267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects of small molecules-poly(A) interaction: an approach to RNA based drug design.
    Giri P; Kumar GS
    Curr Med Chem; 2009; 16(8):965-87. PubMed ID: 19275606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. Role of PKC epsilon in activation loop phosphorylations and PKC delta in hydrophobic motif phosphorylations.
    Rybin VO; Sabri A; Short J; Braz JC; Molkentin JD; Steinberg SF
    J Biol Chem; 2003 Apr; 278(16):14555-64. PubMed ID: 12566450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the cellular targets of bioactive small molecules with activity-based probes.
    Li X; Hu Y
    Curr Med Chem; 2010; 17(27):3030-44. PubMed ID: 20629628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for protein kinase C ligands using fluorescence resonance energy transfer.
    Ohashi N; Nomura W; Minato N; Tamamura H
    Chem Pharm Bull (Tokyo); 2014; 62(10):1019-25. PubMed ID: 25109829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Small Molecule Responsive Split Protein Kinases.
    Castillo-Montoya J; Ghosh I
    Methods Mol Biol; 2017; 1596():307-319. PubMed ID: 28293895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
    Manetti F
    Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.